1-4 of 4
Daniel Ernst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort a of the Multicenter, Open-Label, Phase 2 Waveline-006 Study

Ingrid Glimelius, Won Seog Kim, Ewa Paszkiewicz-Kozik, Daniel Ernst, Reid W. Merryman, Claudia Moreira, Sanfang Tu, Yixin Ren, Katherine Ryland, Uzor C. Ogbu, Pier Luigi Zinzani
Journal: Blood
Blood (2024) 144 (Supplement 1): 4405.
https://doi.org/10.1182/blood-2024-205897
Published: 2024
Journal Articles

Increased Frequency of Low-Grade Follicular Lymphoma with a High Proliferative Index: A First Step Towards Histological Transformation? a Retrospective Analysis of 25 Follicular Lymphoma Cases

Joaquin Díaz Schmidt, Nicolás Triantafilo, Biserka Spralja, Daniel Ernst
Journal: Blood
Blood (2023) 142 (Supplement 1): 6127.
https://doi.org/10.1182/blood-2023-191161
Published: 2023
Journal Articles

Quantitative Ki-67 Proliferative Index Assessment of Human B-Cell Lymphomas By Flow Cytometry

Felipe Castillo, Constanza Morales, Mirentxu Iruretagoyena, Joaquin Díaz Schmidt, Daniel Ernst
Journal: Blood
Blood (2023) 142 (Supplement 1): 6131.
https://doi.org/10.1182/blood-2023-190504
Published: 2023
Journal Articles

Real-World Experience of Venetoclax Combination Therapy in Patients with Acute Myeloid Leukemia (AML): A Single-Institution Retrospective Study in a Middle-Income Country

Natalia Aránguiz, Ximena Valladares, Javiera Donoso, Sebastian Ignacio Ewoldt, Daniel Ernst, Joaquin Diaz, Matias Sanchez
Journal: Blood
Blood (2022) 140 (Supplement 1): 11723–11724.
https://doi.org/10.1182/blood-2022-164899
Published: 2022